[go: up one dir, main page]

MA38497A1 - Il-22 Polypeptides and Fc Il-22 Fusion Proteins and Methods of Use - Google Patents

Il-22 Polypeptides and Fc Il-22 Fusion Proteins and Methods of Use

Info

Publication number
MA38497A1
MA38497A1 MA38497A MA38497A MA38497A1 MA 38497 A1 MA38497 A1 MA 38497A1 MA 38497 A MA38497 A MA 38497A MA 38497 A MA38497 A MA 38497A MA 38497 A1 MA38497 A1 MA 38497A1
Authority
MA
Morocco
Prior art keywords
methods
polypeptides
fusion proteins
relates
agonists
Prior art date
Application number
MA38497A
Other languages
French (fr)
Other versions
MA38497B1 (en
Inventor
Justin Scheer
Wenjun Ouyang
Eric Gary Stefanich
Richard Vandlen
Philip E Haas
Ganesh A Kolumam
Xiaoting Wang
Jed Ross
Bruggen Nicholas Van
Wyne P Lee
Original Assignee
Genentech Inc
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc, Hoffmann La Roche filed Critical Genentech Inc
Priority claimed from PCT/US2014/029652 external-priority patent/WO2014145016A2/en
Publication of MA38497A1 publication Critical patent/MA38497A1/en
Publication of MA38497B1 publication Critical patent/MA38497B1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne des polypeptides d'il-22, des protéines de fusion fc il-22 et des agonistes d'il-22, une composition comprenant ceux-ci, des procédés de fabrication et des procédés d'utilisation de la composition pour le traitement de maladies. L'invention concerne également des réactifs associés au récepteur d'il-22 et leurs procédés d'utilisation.The invention relates to IL-22 polypeptides, IL-22 fusion proteins and IL-22 agonists, a composition comprising the same, methods of making and methods of using the IL-22 polypeptide. the treatment of diseases. The invention also relates to reagents associated with the IL-22 receptor and methods of use thereof.

MA38497A 2013-03-15 2014-03-14 He-22 polypeptides and fc il-22 fusion proteins and methods of use MA38497B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361800148P 2013-03-15 2013-03-15
PCT/US2014/029652 WO2014145016A2 (en) 2013-03-15 2014-03-14 Il-22 polypeptides and il-22 fc fusion proteins and methods of use

Publications (2)

Publication Number Publication Date
MA38497A1 true MA38497A1 (en) 2017-10-31
MA38497B1 MA38497B1 (en) 2018-11-30

Family

ID=56119117

Family Applications (1)

Application Number Title Priority Date Filing Date
MA38497A MA38497B1 (en) 2013-03-15 2014-03-14 He-22 polypeptides and fc il-22 fusion proteins and methods of use

Country Status (2)

Country Link
AR (1) AR095528A1 (en)
MA (1) MA38497B1 (en)

Also Published As

Publication number Publication date
MA38497B1 (en) 2018-11-30
AR095528A1 (en) 2015-10-21

Similar Documents

Publication Publication Date Title
PH12020550205A1 (en) IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
MX380658B (en) REGION FC VARIANTS WITH ENHANCED PROTEIN A BINDING.
PH12019500782A1 (en) Bispecific heterodimeric fusion proteins containing il-15/il-15ralpha fc-fusion proteins and pd-1 antibody fragments
SA517380842B1 (en) Interleukin-2/interleukin-2 receptor alpha fusion proteins and methods of use
PH12019500600A1 (en) Antibodies against signal-regulatory protein alpha and methods of use
MA40882A (en) ANTIGEN BINDING MOLECULES INCLUDING ONE TRIMER OF TNF FAMILY LIGAND
JO3658B1 (en) Fusion proteins
EA202090216A2 (en) BINDING SERUM ALBUMIN DOMAINS FIBRONECTIN III TYPE
FR3038517B1 (en) USE OF MODIFIED FC FRAGMENTS IN IMMUNOTHERAPY
TR201910592T4 (en) New double-targeted protein that specifically binds to dll4 and vegf and its use.
EA201690469A1 (en) Fusion protein
MX387180B (en) FC REGION VARIANTS WITH NEONATAL FC RECEPTOR (FCRN) BINDING PROPERTIES.
MX2019000529A (en) Brain delivery protein.
MX2017014397A (en) Anti-fcrn antibodies.
MA39096B1 (en) Antibodies specific to fcrn
SG10201903142RA (en) Serpin fusion polypeptides and methods of use thereof
MX2019012419A (en) Use of klk5 antagonists for treatment of a disease.
IL276616A (en) Dosing for treatment with il-22 fc fusion proteins
EA201691548A1 (en) EXPRESSING STRUCTURES AND METHODS FOR SELECTION OF CELL HOSPITALS EXPRESSING POLYPEPTIDES
MA32770B1 (en) Igf-1 polypeptide antibody
MX2018013177A (en) Fusion protein comprising ccl3 variant and use thereof cross-reference to related applications.
MA38497A1 (en) Il-22 Polypeptides and Fc Il-22 Fusion Proteins and Methods of Use
MX2021004684A (en) Antibodies specific for glycosylated apoj and uses thereof.
CR20150477A (en) IL-22 POLYPEPTIDES AND IL-22 FC FUSION PROTEINS AND METHODS OF USE
EA202090582A3 (en) POLYPEPTIDES IL-22, CHIMERIC PROTEINS IL-22 FC AND THEIR APPLICATION